PCVX

Vaxcyte, Inc.

Biotechnology · Biotechnology

$230.85 sample

+0.94 (+0.41%) 1D

Market cap

$385.8B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-01

Alerts

8

Price$230.85 +25.31% 3M daily closessample

230.85179.17

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider buy: General Counsel
Sep 24INSInsider sell: Chief Executive Officer
Sep 18INSInsider sell: EVP, Operations
Sep 09INSInsider sell: Chief Financial Officer
Sep 01SEC10-Q filed
Aug 25SECForm 144 filed
Aug 17INSInsider sell: General Counsel
Aug 11SEC10-Q filed

Sign up to see the real PCVX record →

Company facts

SEC EDGAR registration

Name: Vaxcyte, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +2sample, -100 to +100
Reporting currency: USD

Who is positioning in PCVX

sample

Insiders: 15 insider transactions over 90 days, net selling, $119.0M
Congress: 5 members traded over 90 days
Institutions · 13F: 18 funds hold $4.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$19.9B +20.5% y/y

Q4 2024Q3 2026

Inventory$11.3B +6.4% y/y

Q4 2024Q3 2026

Accounts receivable$8.9B +12.1% y/y

Q4 2024Q3 2026

Total debt$22.8B +7.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $241.2B +7.0% 3M
Sample peer B: $289.0B +2.6% 3M
Sample peer C: $272.2B +14.0% 3M
Sample peer D: $168.6B +13.1% 3M
Sample peer E: $381.4B +1.2% 3M